435 related articles for article (PubMed ID: 33259773)
1. Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.
Festa S; Scribano ML; Pugliese D; Bezzio C; Principi M; Ribaldone DG; Allocca M; Mocci G; Bodini G; Spagnuolo R; Vernia P; Mazzuoli S; Costa F; Barberio B; Cosintino R; Zerboni G; Aratari A; Armuzzi A; Papi C
United European Gastroenterol J; 2021 May; 9(4):507-516. PubMed ID: 33259773
[TBL] [Abstract][Full Text] [Related]
2. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
Llaó J; Naves JE; Ruiz-Cerulla A; Gordillo J; Mañosa M; Maisterra S; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
Dig Liver Dis; 2016 Jun; 48(6):608-12. PubMed ID: 27012443
[TBL] [Abstract][Full Text] [Related]
4. Outcome of a conservative approach in severe ulcerative colitis.
Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M
Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785
[TBL] [Abstract][Full Text] [Related]
6. Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN.
Krauthammer A; Tzivinikos C; Assa A; Miele E; Strisciuglio C; Urlep D; Serban ED; Singh A; Winter HS; Russell RK; Hojsak I; Malham M; Navas-López VM; Croft NM; Lee HM; Ledder O; Shamasneh I; Hussey S; Huynh HQ; Wine E; Shah N; Sladek M; de Meij TG; Romano C; Dipasquale V; Lionetti P; Afzal NA; Aloi M; Lee K; Martín-de-Carpi J; Yerushalmy-Feler A; Subramanian S; Weiss B; Shouval DS
J Crohns Colitis; 2019 Dec; 13(12):1518-1526. PubMed ID: 31120524
[TBL] [Abstract][Full Text] [Related]
7. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
[TBL] [Abstract][Full Text] [Related]
8. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
Mocciaro F; Renna S; Orlando A; Rizzuto G; Sinagra E; Orlando E; Cottone M
J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101
[TBL] [Abstract][Full Text] [Related]
10. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
11. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E;
Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
[TBL] [Abstract][Full Text] [Related]
15. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.
Sjöberg M; Magnuson A; Björk J; Benoni C; Almer S; Friis-Liby I; Hertervig E; Olsson M; Karlén P; Eriksson A; Midhagen G; Carlson M; Lapidus A; Halfvarson J; Tysk C;
Aliment Pharmacol Ther; 2013 Aug; 38(4):377-87. PubMed ID: 23799948
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.
Vedamurthy A; Xu L; Luther J; Colizzo F; Garber JJ; Khalili H; Ananthakrishnan AN
Dig Dis Sci; 2018 Oct; 63(10):2740-2746. PubMed ID: 29951797
[TBL] [Abstract][Full Text] [Related]
17. Dose-Intensified Infliximab Rescue Therapy for Severe Ulcerative Colitis Does Not Reduce Short-term Colectomy Rates or Increase Postoperative Complications.
Kosaraju RS; Wong DJ; Roth EM; Cataldo TE; Fabrizio AC; Crowell KT; Feuerstein JD; Messaris E
Dis Colon Rectum; 2022 Oct; 65(10):1232-1240. PubMed ID: 35714346
[TBL] [Abstract][Full Text] [Related]
18. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
[TBL] [Abstract][Full Text] [Related]
19. Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy.
Deiana S; Bagnoli S; Manetti N; Caini S; Giannotta M; Scaringi S; Annese V
Dig Liver Dis; 2016 Dec; 48(12):1432-1437. PubMed ID: 27553087
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.
Halpin SJ; Hamlin PJ; Greer DP; Warren L; Ford AC
World J Gastroenterol; 2013 Feb; 19(7):1091-7. PubMed ID: 23467174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]